Korean Drug Revenue

Korean Drug had revenue of 16.49B KRW in the quarter ending September 30, 2025, a decrease of -3.12%. This brings the company's revenue in the last twelve months to 62.21B, down -16.39% year-over-year. In the year 2024, Korean Drug had annual revenue of 73.00B, down -10.29%.

Revenue (ttm)

62.21B

Revenue Growth

-16.39%

P/S Ratio

0.67

Revenue / Employee

230.42M

Employees

270

Market Cap

41.74B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	73.00B	-8.37B	-10.29%
Dec 31, 2023	81.37B	1.39B	1.74%
Dec 31, 2022	79.98B	5.52B	7.41%
Dec 31, 2021	74.47B	7.68B	11.49%
Dec 31, 2020	66.79B	11.26B	20.28%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
GeneBioTech Co. ,Ltd	92.28B
HLscience	18.10B
Eagle Veterinary Technology Co.,Ltd	42.51B
Korea Arlico Pharm	205.21B
Kyung Nam Pharm	56.18B
RP Bio	134.21B
Jin Yang Pharmaceutical	117.19B
Seoul Pharma	52.43B

Revenue Rankings